Navigating Precision Commercialization: Partnering for Success in Rare & Precision Therapies

Webinar Oncology & Hematology
Date: 18th November 2026
Time: 11am EDT
Location: Online
Watch on demand
Summary
Precision therapies are reshaping the future of medicine and with them, the commercialization playbook.
Biopharma companies now have the opportunity to design leaner, smarter launch strategies tailored to the unique demands of targeted therapies.  Join us to explore how Diaceutics’ new model for Precision Commercialization delivers a true partnership, purpose-built for the complexity of precision medicine.
Hear firsthand from Sarah Kurz, President & COO of Partner Therapeutics, as she shares her experience collaborating with Diaceutics to bring this innovative approach to life.
Key Learning Objectives/Topics included:

  • Discover how you can design more agile and cost-effective launch models tailored to the specific demands of precision therapies

  • Understand how Diaceutics’ Precision Commercialization model fosters deep collaboration between stakeholders to streamline execution.

  • Gain insights into how proprietary clinical data and real-time engagement tools can inform decision-making and accelerate market adoption.

Speakers:
Rebecca Fryer
Head of Commercial Partnerships, Diaceutics

Rebecca Fryer is the Head of Commercial Partnerships at Diaceutics, where she leads the Diaceutics Precision Commercialization Incubator. Her role focuses on advancing and refining the company's precision commercialization strategy and offerings. With a robust background in health and life sciences consulting, she has extensive experience in leading the development of complex corporate strategies and implementing strategic change programs for health providers and biopharma. Rebecca is passionate about improving testing, treatment adoption, and ultimately patient outcomes, ensuring that diagnostically enabled therapies reach their full potential. 

Connect
Sarah Kurz
President and Chief Operating Officer, Partner Therapeutics
Connect
Peter Finlayson
Vice President, Marketing, Partner Therapeutics
Connect

WATCH ON DEMAND

Commercial Strategy Optimization Oncology & Hematology Pre-launch Launch
Share:

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.